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Potentially all microorganisms are able to synthesize several substances in vitro 
with inhibitory activity for themselves or other microorganisms, producing 
bactericidal or bacteriostatic effects. The objective of this work was to 
establish the bacterial growth antagonistic properties of Escherichia coli ESBL 
by Lactobacillus casei strain Shirota, Bifidobacterium animalis DN173010, 
isolated of commercial probiotic products, and Kefir grain by the overcoated 
agar method. Analysis of the results allowed to gauge halos of 7.1 ± 2 mm 
inhibition of growth by L. casei strain Shirota and 6.3 ± 2 mm by B. animalis 
DN173010, Kefir grains did not produce inhibition halos against the 
multiresistant strain. The bacterial growth inhibition activity can be justified by 
the competition of nutrients from the medium and/or by the secretion of 
bacteriocins, protein or peptidic compounds ribosomally synthesized in the 
primary metabolism with antagonistic activity and because proteins are 
  
expected to behave differently on certain target microorganisms and culture 
conditions, and the production of these compounds by the Kefir grains 
cannot be excluded. 
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